Effect of the reversible monoamine oxidase A-inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 179-192

  Haddjeri, Nasser ^a   De Montigny, Claude ^a   Curet, Olivier ^b   Blier, Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SANOFI   (France)

Author keywords

(5 hydroxytryptamine, 5 HT); 5 HT(1A) receptor; Befloxatone; Dorsal raphe; Hippocampus; Monoamine oxidase A; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMINE OXIDASE (FLAVIN CONTAINING); BEFLOXATONE; BRAIN MONOAMINE; CLONIDINE; LYSERGIDE; MONOAMINE OXIDASE A INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; QUISQUALIC ACID; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DORSAL RAPHE NUCLEUS; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MICROIONTOPHORESIS; NONHUMAN; NORADRENERGIC NERVE; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION; SINGLE UNIT ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

AFFERENT PATHWAYS; ANIMALS; ELECTRIC STIMULATION; HIPPOCAMPUS; LOCUS COERULEUS; MALE; MONOAMINE OXIDASE INHIBITORS; NEURONS; NOREPINEPHRINE; OXAZOLES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0032545960     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01552-5     Document Type: Article

References (62)

1. Aghajanian, G.K., 1978. Feedback regulation of central monoaminergic neurons: Evidence from single cell recording studies. In: Youdim, M.B.H., Lovenberg, W., Sharman, D.F., Lagnado, J.R. (Eds.), Essays in Neurochemistry and Neuropharmacology. J. Wiley and Sons, New York, pp. 2-32.
2. Aghajanian G.K., Graham A.W., Sheard M.H. Serotonin-containing neurons in brain. Depression of firing by monoamine oxidase inhibitors. Science. 169:1970;1100-1102.
3. Anderson C.D., Pasquier D.A., Forbes W.B., Morgane P.J. Locus coeruleus to dorsal raphe input examined by electrophysiological and morphological methods. Brain. Res. Bull. 2:1977;209-221.
4. Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 19:1980;355-363.
5. Baraban J.M., Aghajanian G.K. Noradrenergic innervation of serotoninergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography. Brain Res. 204:1981;1-11.
6. Blier P., Bouchard C. Modulation of 5-HT release in guinea-pig brain following long-term administration of antidepressant drugs. Br. J. Pharmacol. 113:1994;485-495.
7. Blier P., De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
8. Blier P., De Montigny C. Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience. 16:1985;949-955.
9. 1A agonist gepirone: Electrophysiological studies in the rat brain. Synapse. 1:1987;470-480.
10. Blier P., De Montigny C., Azzaro A.J. Modification of serotoninergic and noradrenergic neurotransmission by repeated administration of monoamine oxidase inhibitors: Electrophysiological studies in the rat central nervous system. J. Pharmacol. Exp. Ther. 237:1986;987-994.
11. Blier P., De Montigny C., Azzaro A.J. Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: Electrophysiological studies in the rat CNS. Naunyn-Schmiedebergs Arch. Pharmacol. 334:1986;253-260.
12. Blier P., Steinberg S., Chaput Y., De Montigny C. Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: A single-cell study in the rat dorsal raphe nucleus. Can. J. Physiol. Pharmacol. 67:1989;98-103.
13. 3H ]-serotonin release in rat hypothalamic slices Naunyn Schmiedeberg's Arch. Pharmacol. 339:1989;60-64.
14. 1A receptors in dorsal raphe and hippocampus: I. Effect spiperone. J. Pharmacol. Exp. Ther. 265:1993;7-15.
15. 1A receptors in dorsal raphe and hipocampus: II. Effect pertussis and cholera toxins. J. Pharmacol. Exp. Ther. 265:1993;16-23.
16. Caille D., Bergis O.E., Fankhauser C., Gardes A., Adam R., Charieras T., Grosset A., Rovel V., Jarreau F.X. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile. J. Pharmacol. Exp. Ther. 277:1996;265-278.
17. Clement H.-W., Gemsa D., Weseman W. Serotonin-norepinephrine interactions: A voltametric study on the effect of serotonin receptor stimulation followed in the nucleus raphe dorsalis and the locus coeruleus of the rat. J. Neural. Transm. 88:1992;11-23.
18. Clement H.-W., Gemsa D., Weseman W. The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetry. Eur. J. Pharmacol. 217:1992;43-48.
19. Chaput Y., De Montigny C. Effects of the 5-HT1 receptor antagonist BMY 7378 on the 5-HT neurotransmission: Electrophysiological studies in the rat central nervous system. J. Pharmacol. Exp. Ther. 246:1988;359-370.
20. Chaput Y., Blier P., De Montigny C. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotoninergic terminals. J. Neurosci. 6:1986;2796-2801.
21. Curet O., Damoiseau G., Labaune J.P., Rovel V., Jarreau F.X. Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum in freely moving rats. J. Neural. Transm. 41:1994;349-355.
22. Curet, O., Damoiseau, G., Aubin, N., Sauvage, S., Sontag, N., Carter, C., Benavides, J., Scatton, B., 1995. Biochemical profile of befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. Soc. Neurosci. Abstr. 21, 677.5.
23. Curet O., Damoiseau G., Aubin N., Sontag N., Rovei V., Jarreau F.X. Befloxatone, a new reversible and selective monoamine. I. Biochemical profile. J. Pharmacol. Exp. Ther. 277:1996;253-264.
24. 1A receptor antagonist on rat cortical serotonin release. XX C.I.N.P. Congress. Melbourne, Australia, p. 5.3.
25. Da Prada M., Kettler R., Keller H.H., Burkard W.P., Haefely W.E. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors. J. Neural. Transm. 28:1989;5-20.
26. 1D autoreceptors. Br. J. Pharmacol. 114:1995;1107-1109.
27. Denney R.M., Denney C.B. An update on the identity crisis of monoamine oxidase: New and old evidence for the independence of MAO A and B. Pharmacol. Ther. 30:1985;227-258.
28. 1A receptor antagonist. Br. J. Pharmacol. 112:1994;91P.
29. 1A receptor antagonist. Behav. Brain. Res. 73:1996;337-353.
30. 1A autoreceptor antagonists restore serotonergic neuronal activity after acute fluoxetine treatment in behaving cats. Soc. Neurosci. Abstr. 21, 386.18.
31. 2-adrenoceptors on rat central neurones. Eur. J. Pharmacol. 105:1984;265-272.
32. Garrat J.C., Crespi F., Mason R., Marsden C.A. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function. Eur. J. Pharmacol. 193:1991;87-93.
33. 2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn Schmiedebergs Arch. Pharmacol. 314:1980;223-230.
34. 2-adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J. Pharmacol. Exp. Ther. 277:1996;861-871.
35. Haddjeri N., De Montigny C., Blier P. Modulation of the firing activity of locus coeruleus neurons in the rat by the 5-HT system. Br. J. Pharmacol. 120:1997;865-875.
36. 1A receptors in the rat hippocampus prevent their inactivation by pertussis toxin. Neurosience. 61:1994;21-30.
37. Hensler J.G., Ferry R.C., Labow D.M., Kovashich G.B., Frazer A. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from dorsal raphe nucleus. Synapse. 17:1994;1-15.
38. Héry F., Faudon M., Ternaux J.P. In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat. Brain Res. Bull. 8:1982;123-129.
39. Jahng J.W., Houpt T.A., Wessel T.C., Chen R., Shih J.C., Joh T.H. Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse. 25:1997;30-36.
40. Johnston J.P. Some observations on a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol. 17:1968;1287-1297.
41. Jones B.E., Yang T.-Z. The efferent projections from reticular formation and locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J. Comp. Neurol. 242:1985;56-92.
42. Kandel E.R., Spencer W.A. Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing. J. Neurophysiol. 24:1961;243-259.
43. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 352:1995;141-148.
44. Loizou L.A. Projections of the nucleus locus coeruleus in the albino rat. Brain Res. 15:1969;563-566.
45. Luppi P.-H., Aston-Jones G., Akaoka H., Chouvet G., Jouvet M. Afferent projections to rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neuroscience. 65:1995;119-160.
46. 2-adrenoceptors of 5-hydroxytryptamine terminals in rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 347:1993;266-272.
47. 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology. 10:1994;41-51.
48. Murphy, D.L., Aulakh, C.S., Garrick, N.A., Sunderland, T., 1987. Monoamine oxidase inhibitors as antidepressants: Implications for the mechanism of action of antidepressants and the psychobiology of affective disorders and some related disorders. In: Meltzer, H.Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp. 545-556.
49. Oleskovich S., Descarries L. Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience. 34:1990;19-33.
50. Paxinos, G. and Watson, C., 1982. The rat brain in stereotaxic coordinates. Academic Press. Sydney.
51. 1D receptors: Effect of tetrodotoxin, G protein and long-term antidepressant administration. J. Pharmacol. Exp. Ther. 276:1996;697-707.
52. 1D receptors regulate 5-HT release in the rat raphe nuclei: In vivo voltammetry and in vitro superfusion studies. Neuropsychopharmacology. 13:1995;249-260.
53. Ranck, J.B., 1975. Behavioral correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats. In: Isaacson, R.L., Pribram, K.H. (Eds.), The Hippocampus. Plenum, New York, pp. 207-244.
54. 1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology. 15:1996;349-360.
55. 3H ]Ro 19-6327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs and human brain J. Neurosci. 12:1992;1977-1990.
56. Schechter L.E., Balaños F.J., Golzan G., Lanfumey L., Haj-Dahmane S., Laporte A.-M., Fattaccini C.-M., Hamon M. Alterations of central serotonergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: Biochemical and electrophysiological studies. J. Pharmacol. Exp. Ther. 255:1990;1335-1347.
57. Svensson T.H., Bunney B.S., Aghajanian G.K. Inhibition of both NA and 5-HT neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92:1975;291-306.
58. Thase M.E., Trivedi M.H., Rush A.J. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology. 12:1995;185-219.
59. Westlund K.N., Denney R.M., Kochersperger L.M., Rose R.M., Abell C.W. Distinct monoamine A and B populations in primate brain. Science. 230:1985;181-183.
60. Yang H.Y., Neff N.H. β-phenylethylamine: A specific substrate for type B monoamine oxidase of brain. J. Pharmacol. Exp. Ther. 187:1973;365-372.
61. Youdim M.B.H. The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction. Acta Psychiatr. Scand. 91:1995;5-22.
62. Youdim M.B.H., Finberg J.P.M. New directions in monoamine oxidase A and B: Selective inhibitors and substrates. Biochem. Pharmacol. 41:1991;155-162.